Immunic, Inc.
IMUX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $171 | $92 | $110 | $90 |
| - Cash | $35 | $55 | $14 | $36 |
| + Debt | $0 | $1 | $1 | $1 |
| Enterprise Value | $136 | $38 | $97 | $55 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$26 | -$27 | -$27 | -$25 |
| % Margin | – | – | – | – |
| Net Income | -$26 | -$27 | -$25 | -$25 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.13 | -0.2 | -0.25 | -0.28 |
| % Growth | 35% | 20% | 10.7% | – |
| Operating Cash Flow | -$20 | -$25 | -$22 | -$23 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$20 | -$25 | -$22 | -$23 |